CD28 and neoplasm: When compared to CD28, 4-1BB co-stimulated CARs showed slower onset of cytotoxicity, but longer durability and accumulation of CAR cells over time, which ultimately resulted in comparable efficacy but slower kinetics of the anti-tumor response [107].